Xeris Pharmaceuticals
XERS
#6686
Rank
โ‚น44.26 B
Marketcap
โ‚น296.94
Share price
2.35%
Change (1 day)
70.82%
Change (1 year)

Revenue for Xeris Pharmaceuticals (XERS)

Revenue in 2024 (TTM): โ‚น15.63 Billion

According to Xeris Pharmaceuticals's latest financial reports the company's current revenue (TTM ) is โ‚น15.94 Billion. In 2023 the company made a revenue of โ‚น13.64 Billion an increase over the revenue in the year 2022 that were of โ‚น9.12 Billion. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.

Revenue history for Xeris Pharmaceuticals from 2017 to 2024

Annual revenue

Year Revenue Change
2024 (TTM) โ‚น15.63 B14.57%
2023 โ‚น13.64 B49.57%
2022 โ‚น9.12 B145.98%
2021 โ‚น3.70 B150.08%
2020 โ‚น1.48 B673.43%
2019 โ‚น0.19 B11.25%
2018 โ‚น0.17 B73.48%
2017 โ‚น99.35 M

Revenue for similar companies or competitors

Company Revenue Revenue differencediff. Country
N/AN/A๐Ÿ‡บ๐Ÿ‡ธ USA